BioXcel Therapeutics Inc. (BTAI) Surged 5.7% or 0.53 To Price $9.83 On Friday


BioXcel Therapeutics Inc. (BTAI) surged 5.7% or 0.53 to $9.83. It is near to 102595 shares traded, which is 191.03% compare to the average total volume 53705. The market cap of BTAI is $153.80 million. The year to date change is -9.99%. The 52 week price range is from $6.76 to $11.94. Price of BTAI have changed 2.42% during last week. It have changed -13.57% over last month, -15.91% over last 3 months, -15.68% over last 6 months and -15.68% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BTAI is 9.47. It is -3.66% below current price. The 52-week High is 11.94. It is 21.46% from the current price. The 52-week Low is 6.76. It is -31.23% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of BTAI is 0.75 on 2018-06-15. Short % to float is 0.20%. There are some statistics of BTAI. It is has market cap $153.80 million. The share outstanding is 15.65 million. The average volume is 53705. The percent of top 15 Institution holding is 29.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BTAI is -15.91%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BTAI is -14.72%.


Tags:

Share this post